Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

2.2K
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
2.2K
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

685
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
685

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum neurofilament light chain in paediatric patients treated with natalizumab for highly active multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same authorSame journal

Immuno-Proteomic Features Associated to Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Simultaneous T<sub>2</sub>, T<sub>2</sub>*, and R<sub>2</sub>' Mapping for Multiple Sclerosis Using Nonlinear Model-Based Reconstruction of Undersampled Radial RARE-EPI MRI.

Magnetic resonance in medicine·2026
Same author

De novo variants in LDB1 are linked to distinct neurodevelopmental phenotypes determined by variant location and differing pathomechanisms.

American journal of human genetics·2026
Same author

Efficacy of Inebilizumab in N-MOmentum Trial Participants With or Without Prior Immunosuppressants.

Annals of clinical and translational neurology·2026
Same author

Immune-metabolic trajectories delineate subgroups in paediatric long COVID.

Nature communications·2026
Same journal

Abnormal B-Cell Exosome Proapoptotic and Antiapoptotic Cargo in Multiple Sclerosis: Potential Implication in Progressive Disease Biology.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same journal

Isolated Peripheral Nervous System Presentation in Ma/Ma2-Associated Autoimmunity.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same journal

Immunity Gone Viral: Subacute Cognitive Decline With Multifocal Brain Lesions in Neuromyelitis Optica Spectrum Disorder.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same journal

Specific HLA-DRB1 Alleles Associate With Anti-Caspr1 and Anti-CNTN1 Autoantibodies in Autoimmune Nodopathies.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same journal

Prognostic Biomarker Signature of Relapse in Neuromyelitis Optica Spectrum Disorders in the CIRCLES Observational Study.

Neurology(R) neuroimmunology & neuroinflammation·2026
See all related articles

Related Experiment Video

Updated: May 20, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.3K

The Inner Nuclear Layer in Pediatric Multiple Sclerosis.

Hannah Hummel-Abmeier1,2, Sabine Naxer3, Ella Maria Kadas4,5

  • 1Division of Pediatric Neurology, Department of Pediatrics and Adolescent Medicine, University Medical Center Göttingen, Georg-August-Universität Göttingen, Germany.

Neurology(R) Neuroimmunology & Neuroinflammation
|March 26, 2025
PubMed
Summary
This summary is machine-generated.

In pediatric multiple sclerosis (MS), the inner nuclear layer (INL) thickens after optic neuritis (ON), unlike other retinal layers that thin. INL thickness did not correlate with disease severity in this study.

More Related Videos

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.2K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.6K

Related Experiment Videos

Last Updated: May 20, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.3K
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.2K
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

8.6K

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Pediatric Neurology

Background:

  • Pediatric onset multiple sclerosis (POMS) causes optic nerve and retinal damage, including thinning of the peripapillary retinal nerve fiber layer (pRNFL) and macular ganglion cell and inner plexiform layer (GCIP).
  • The inner nuclear layer (INL) thickness is hypothesized to increase with inflammation or after acute optic neuritis (ON) and decrease with neurodegeneration.
  • Macular microcysts in the INL have been observed in adult MS patients.

Purpose of the Study:

  • To investigate the inner nuclear layer (INL) in a large cohort of pediatric onset multiple sclerosis (POMS) patients.
  • To evaluate the INL as a potential biomarker for disease course and therapeutic success in POMS.
  • To compare INL changes in POMS with and without a history of optic neuritis (ON) to healthy controls.

Main Methods:

  • A cross-sectional case-control study involving 153 patients with POMS and 92 controls.
  • Prospective recruitment of participants, including asymptomatic healthy volunteers and children with nonretinal disorders.
  • Optical coherence tomography (OCT) with intraretinal segmentation and best-corrected visual acuity (BCVA) assessment.

Main Results:

  • Eyes with POMS and prior ON showed increased INL thickness (44.31 µm) compared to controls (42.96 µm, p=0.014).
  • pRNFL (83 µm) and GCIP thickness (68.42 µm) were reduced in POMS eyes with prior ON compared to controls (pRNFL 97 µm, GCIP 78.53 µm).
  • No significant differences in INL or other layer thicknesses were found in POMS eyes without ON history compared to controls. pRNFL and GCIP loss correlated with worse BCVA, but INL thickness did not.

Conclusions:

  • The INL in POMS exhibits changes comparable to adult MS, though macular microcysts are considerably rarer.
  • The absence of a cross-sectional association between INL thickness and disease severity suggests early-stage disease where neuroinflammation, rather than neurodegeneration, is predominant.
  • Further longitudinal studies are needed to clarify the role of INL changes as a biomarker in POMS.